Search - tctmd.com

Displaying 821 - 840 of 2772

Sort: Relevancy | Date

Presentation TCT 2024

M-TEER for Moderate to Severe FMR in Symptomatic Heart Failure: Comparison of RESHAPE-HF2 Trial Results With Outcomes in MITRA-FR and COAPT

Presenter: Stefan Anker

October 27, 2024

Presentation TCT 2024

TCT 149: Institutional Volume and Failure to Rescue in Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry

Presenter: Jayakumar Sreenivasan

October 27, 2024

Presentation ESC 2024

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Presenter: Gi-Byoung Nam

September 01, 2024

Presentation ESC 2024

Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis

Presenter: Pardeep S. Jhund

September 01, 2024

Presentation ESC 2024

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Presenter: Muthiah Vaduganathan

September 01, 2024

Presentation ESC 2024

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Presenter: Erwan Donal

August 31, 2024

Presentation ESC 2024

Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

Presenter: Volker Rudolph

August 31, 2024

Presentation NY Valves 2024

Interventional Approaches to Septal Reduction Therapy

Presenter: Srihari S. Naidu

June 07, 2024

Presentation NY Valves 2024

Is there Still a Role for Surgery in HCM?

Presenter: Hiroo Takayama

June 07, 2024

Presentation NY Valves 2024

Myosin Inhibitors and Novel Medical Therapies for HCM

Presenter: Mark V. Sherrid

June 07, 2024

Presentation NY Valves 2024

The SESAME Procedure for Obstructive HCM.

Presenter: Jaffar M. Khan

June 07, 2024

Presentation NY Valves 2024

A Clinical Approach to Genetics in Hypertrophic Cardiomyopathy

Presenter: Martin Maron

June 07, 2024

Presentation NY Valves 2024

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

Presenter: Anita W. Asgar

June 07, 2024

Presentation NY Valves 2024

Characteristics, Outcomes, and Management of Patients With Degenerated Trifecta Valves

Presenter: Taha Hatab

June 07, 2024

Presentation NY Valves 2024

RV Failure After TTVR: Frequency, Diagnosis, and Therapeutic Options

Presenter: Michael I. Brener

June 07, 2024

Presentation NY Valves 2024

Feasibility of Redo Transcatheter Aortic Valve Replacement (Redo TAV) in Bicuspid Aortic Valves

Presenter: Atsushi Okada

June 07, 2024

Presentation NY Valves 2024

Redo Mitral Valve-in-Valve Intervention: Not All Failures Are the Same!

Presenter: Curtiss T. Stinis

June 07, 2024

Presentation NY Valves 2024

Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

Presenter: Philippe Genereux

June 07, 2024

Presentation NY Valves 2024

CT Observations On Achieving the "Optimal" TAVR Implantation: Can We Avoid TAVR Failures?

Presenter: Joao L. Cavalcante

June 07, 2024

Presentation NY Valves 2024

Debate Con: Echo First and Only to Diagnose Bioprosthetic Valve Dysfunction /Failure

Presenter: Rebecca T. Hahn

June 06, 2024

Advertisement

M-TEER for Moderate to Severe FMR in Symptomatic Heart Failure: Comparison of RESHAPE-HF2 Trial Results With Outcomes in MITRA-FR and COAPT

TCT 149: Institutional Volume and Failure to Rescue in Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

Interventional Approaches to Septal Reduction Therapy

Is there Still a Role for Surgery in HCM?

Myosin Inhibitors and Novel Medical Therapies for HCM

The SESAME Procedure for Obstructive HCM.

A Clinical Approach to Genetics in Hypertrophic Cardiomyopathy

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

Characteristics, Outcomes, and Management of Patients With Degenerated Trifecta Valves

RV Failure After TTVR: Frequency, Diagnosis, and Therapeutic Options

Feasibility of Redo Transcatheter Aortic Valve Replacement (Redo TAV) in Bicuspid Aortic Valves

Redo Mitral Valve-in-Valve Intervention: Not All Failures Are the Same!

Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

CT Observations On Achieving the "Optimal" TAVR Implantation: Can We Avoid TAVR Failures?

Debate Con: Echo First and Only to Diagnose Bioprosthetic Valve Dysfunction /Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content